<DOC>
	<DOC>NCT00293709</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety profile and the effectiveness of etanercept under usual care settings in patients with PsA treated by dermatologists.</brief_summary>
	<brief_title>Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists</brief_title>
	<detailed_description>Non-interventional study: subjects to be selected according to the usual clinical practice of their physician</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Arthritis, Psoriatic</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Skin Diseases, Papulosquamous</mesh_term>
	<mesh_term>Etanercept</mesh_term>
	<criteria>Clinical diagnosis of Psoriatic Arthritis Sepsis or risk for sepsis, Acute infection, Hypersensitive against Etanercept</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Arthritis</keyword>
</DOC>